New Russian fund targets financial and medical startups

Confirming that the Russian venture industry, though declining, is far from agonizing, a new fund was launched last month in Moscow with $10 million under management.

Christened ‘RB Capital,’ the fund intends to invest in financial and medical technologies in Russia and abroad. It will target, in particular, startups in the fields of open source, B2B cloud technologies, risk management solutions, artificial intelligence, data analytics, predictive modeling, Internet-of-Things, and wearable gadgets.

RB Capital will inject from $100,000 to $1 million in each startup, Rusbase has reported, based on exchanges with the company.

In addition to financial support, the fund intends to participate actively in the development of its portfolio companies.

Behind the new fund is RB Partners, a Russian investment advisory and management firm, which claims to have completed over 70 M&A projects exceeding $2 billion since its foundation in 2004. The firm has also invested in three IT companies in Moscow and St. Petersburg.

 

Topics: Finance, News, Venture / Private equity
Scroll to Top

This site is under maintenance. Sorry for the inconvenience.

This site is under maintenance. Sorry for the inconvenience.